112 related articles for article (PubMed ID: 3526459)
1. [Organ-specific autoantibodies in type I diabetic patients and their relatives].
Campea L; Vela M; Candela A; Raponi MP; Napoleone E; Strappini P; Betterle C; Orsini M
Recenti Prog Med; 1986 May; 77(5):226-32. PubMed ID: 3526459
[No Abstract] [Full Text] [Related]
2. [Autoimmunological phenomena in diabetes, particularly of the juvenile type].
Dudziński W
Pol Tyg Lek; 1977 Sep; 32(39):1525-7. PubMed ID: 335363
[No Abstract] [Full Text] [Related]
3. Coincidence of high antiislet and antithyroid autoantibody titles in first-degree relatives of patients with type 1 diabetes.
Sougioultzoglou F; Falorni A; Kassi G; Brozzetti A; Karamitsos D; Koliakos GG
Exp Clin Endocrinol Diabetes; 2005 Feb; 113(2):85-9. PubMed ID: 15772899
[TBL] [Abstract][Full Text] [Related]
4. Islet cell and other organ-specific autoantibodies in Chinese children with insulin-dependent diabetes mellitus.
Tsai WY; Riley WJ; Lee JS; Tsai WS
J Formos Med Assoc; 1990 Nov; 89(11):969-71. PubMed ID: 1982128
[TBL] [Abstract][Full Text] [Related]
5. Clinical and subclinical organ-specific autoimmune manifestations in type 1 (insulin-dependent) diabetic patients and their first-degree relatives.
Betterle C; Zanette F; Pedini B; Presotto F; Rapp LB; Monciotti CM; Rigon F
Diabetologia; 1984 Jun; 26(6):431-6. PubMed ID: 6381190
[TBL] [Abstract][Full Text] [Related]
6. [Diabetes mellitus type I, thyroid gland autoimmunity, thyroid gland function and HLA status].
Kehr S; Gastauer R; Winkler G
Monatsschr Kinderheilkd; 1985 Oct; 133(10):738-42. PubMed ID: 3906379
[TBL] [Abstract][Full Text] [Related]
7. [Islet-cell antibodies and organ-specific antibodies in diabetic children and adolescents. Relationship with age, age at onset, duration of diabetes, residual insulin secretion and retinopathy (author's transl)].
Dorchy H; Lemiere B; Toussaint D; Gausset P
Nouv Presse Med; 1981 Sep; 10(34):2795-8. PubMed ID: 7031599
[TBL] [Abstract][Full Text] [Related]
8. Human monoclonal autoantibodies that react with both pancreatic islets and thyroid.
Garzelli C; Taub FE; Jenkins MC; Drell DW; Ginsberg-Fellner F; Notkins AL
J Clin Invest; 1986 May; 77(5):1627-31. PubMed ID: 3009548
[TBL] [Abstract][Full Text] [Related]
9. Serum anti-p53 autoantibodies in patients with type 1 diabetes.
Di Cesare E; Previti M; Lombardo F; Di Benedetto A; Mazzù N; Romano G; De Luca F; Lasco A; Cucinotta D
Ann Clin Lab Sci; 2001 Jul; 31(3):253-8. PubMed ID: 11508828
[TBL] [Abstract][Full Text] [Related]
10. [Detection of antibodies against pancreatic islet cells in clinical practice].
Pánczél P; Külkey O; Luczay A; Bornemisza B; Illyés G; Halmos T; Baranyi E; Blatniczky L; Mészáros J; Kerényi Z; Geró L; Tamás G; Hosszúfalusi N; Horváth L; Madácsy L; Romics L
Orv Hetil; 1999 Nov; 140(48):2695-701. PubMed ID: 10645715
[TBL] [Abstract][Full Text] [Related]
11. Islet autoantibodies, nationality and gender: a multinational screening study in first-degree relatives of patients with Type I diabetes.
Williams AJ; Bingley PJ; Moore WP; Gale EA;
Diabetologia; 2002 Feb; 45(2):217-23. PubMed ID: 11935153
[TBL] [Abstract][Full Text] [Related]
12. A universal model of antibody prediction (MAP) of type 1 diabetes in children.
Elliott RB; Pilcher CC
J Autoimmun; 1994 Dec; 7(6):881-8. PubMed ID: 7888044
[TBL] [Abstract][Full Text] [Related]
13. Organ-specific autoantibodies in coeliac disease: do they represent an epiphenomenon or the expression of associated autoimmune disorders?
Volta U; De Franceschi L; Molinaro N; Tetta C; Bianchi FB
Ital J Gastroenterol Hepatol; 1997 Feb; 29(1):18-21. PubMed ID: 9265573
[TBL] [Abstract][Full Text] [Related]
14. The evaluation of thyroid and islet autoantibodies in type 1 diabetes mellitus.
Prázný M; Skrha J; Límanová Z; Hilgertová J
Sb Lek; 1999; 100(3):205-11. PubMed ID: 11221467
[TBL] [Abstract][Full Text] [Related]
15. Comparison of juvenile diabetics with positive and negative organ specific antibody titers. Evidence for genetic heterogeneity.
Nissley SP; Drash AL; Blizzard RM; Sperling M; Childs B
Diabetes; 1973 Jan; 22(1):63-5. PubMed ID: 4683797
[No Abstract] [Full Text] [Related]
16. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children.
Yamamoto AM; Deschamps I; Garchon HJ; Roussely H; Moreau N; Beaurain G; Robert JJ; Bach JF
J Autoimmun; 1998 Dec; 11(6):643-50. PubMed ID: 9878086
[TBL] [Abstract][Full Text] [Related]
17. Concordance for islet autoimmunity among monozygotic twins.
Redondo MJ; Jeffrey J; Fain PR; Eisenbarth GS; Orban T
N Engl J Med; 2008 Dec; 359(26):2849-50. PubMed ID: 19109586
[No Abstract] [Full Text] [Related]
18. Prevalence of organ-specific autoantibodies in childhood- and adult-onset type 1 diabetes.
Allen S; Huber J; Devendra D
Ann N Y Acad Sci; 2008 Dec; 1150():260-2. PubMed ID: 19120308
[TBL] [Abstract][Full Text] [Related]
19. [Islands of Langerhans' autoantibodies in patients with insulin-dependent diabetes mellitus].
Gomes MB; Quadra AA; Vieira LM; Sarno EN
AMB Rev Assoc Med Bras; 1985; 31(3-4):59-61. PubMed ID: 3909246
[No Abstract] [Full Text] [Related]
20. Heterogeneity of islet cell cytoplasmic antibodies and autoantibodies to glutamate decarboxylase in relatives of patients with type 1 (insulin-dependent) diabetes.
Bergerot I; Souchier C; Thivolet C
C R Acad Sci III; 1993 Nov; 316(11):1368-73. PubMed ID: 8087616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
